4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-043963
EVP and COO sold 356 shares at $15.67 ($5,579)
- EVP and COO acquired 962 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wolff Stefani EVP and COO | 2022-07-30 | Option exercise | +962 | 1,594 | D: show line 1 in the form | ||
| Wolff Stefani EVP and COO | 2022-08-01 | Sale | −356 | $15.67 | $5,579 | 1,238 | D: show line 2 in the form |
| Open-market sales · 356 sh · avg $15.67 · $5,579 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Wolff Stefani EVP and COO | 2022-07-30 | Option exercise · Restricted Stock Units | −962 | 13,468 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…